South Australian hepatitis B community education projects are but a small selection of the 40 projects progressively being implemented Australia-wide.
Abstract submissions for oral and poster presentations are now open for the Australian Viral Hepatitis Elimination Conference 2017.
Understanding hepatitis A, B and C may not be quite as simple as ABC, but a session with Hepatitis SA's highly skilled educators will certainly help you get there.
As Australians with hepatitis C are being cured at unprecedented rates, those living with hepatitis B are looking forward to a new treatment which promises the same efficacy as current drugs but with less toxic side effects.
The Therapeutic Goods Administration (TGA) has warned that direct-acting antiviral (DAA) medicines for the treatment of chronic hepatitis C virus (HCV) infection have been associated with reactivation of hepatitis B virus (HBV) in people with a current or previous HBV infection.
The Pharmaceutical Benefits Scheme (PBS) and the Gastroenterological Society of Australia (GESA) have published information for health professionals to help them manage the new hepatitis C treatments.
This article has been updated to include the new hepatitis C treatment consensus guidelines from January 2017.
Guide to South Australian community pharmacies which dispense the new hepatitis C medicines.
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C. This includes people with hepatitis B or C, their family and friends, and professionals who support them. We also provide hepatitis C and clean needle program (CNP) peer education and support services, and operate a CNP secondary site.